Design Therapeutics, Inc.

Q3 2025 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
95
Total reported value, excl. options
$260M
Manager Report Date Value ($000) Shares Option Type